Creative Planning’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Creative Planning’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,034	Closed	-$49K	–	2180
2018 Q3	$49K	Hold	3,034	–	–	﹤0.01%	1883
2018 Q2	$110K	Buy	3,034 +469	+18%	+$16.2K	﹤0.01%	1752
2018 Q1	$80K	Hold	2,565	–	–	﹤0.01%	1778
2017 Q4	$99K	Hold	2,565	–	–	﹤0.01%	1731
2017 Q3	$55K	Buy	2,565 +267	+12%	+$4.96K	﹤0.01%	1766
2017 Q2	$46K	Buy	2,298 +1,025	+81%	+$21.2K	﹤0.01%	2585
2017 Q1	$28K	Hold	1,273	–	–	﹤0.01%	2898
2016 Q4	$10K	Hold	1,273	–	–	﹤0.01%	3574
2016 Q3	$27K	Hold	1,273	–	–	﹤0.01%	2848
2016 Q2	$34K	Buy	1,273 +426	+50%	+$11.7K	﹤0.01%	2414
2016 Q1	$31K	Buy	+847	New	+$31.4K	﹤0.01%	2437

Other funds holding BLPH

NMVA

New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return

PCM

Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Creative Planning's BLPH Position: Q4 2018 in Review

Creative Planning sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2018, closing a stake of 3,034 shares — an estimated $49K sold.

Creative Planning first reported a position in BLPH in Q1 2016 and held it in 11 quarters. The position peaked at $110K in Q2 2018. 25 funds tracked by Wall St. Rank hold BLPH as of Q4 2018.

Creative Planning reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
Creative Planning sold 3,034 Bellerophon Therapeutics, Inc. shares in Q4 2018, an estimated $49K.
Creative Planning first reported a position in Bellerophon Therapeutics, Inc. in Q1 2016 and held it in 11 quarters.
Creative Planning's Bellerophon Therapeutics, Inc. position peaked at $110K in Q2 2018.
25 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2018.

Based on Creative Planning's 13F filing for Q4 2018, filed 1 Feb 2019.